US8822505, 27::US8822505, 28

ID: ALA3671341

Chembl Id: CHEMBL3671341

PubChem CID: 71680049

Max Phase: Preclinical

Molecular Formula: C32H33Cl2F4N5O7S

Molecular Weight: 778.61

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  C[C@H](Oc1ccc(S(=O)(=O)[C@@H]2C[C@@H](C(=O)NC3(C#N)CC3)N(C(=O)C3(c4ncc(Cl)cc4F)CCN3C(=O)OC(C)(C)C)C2)c(Cl)c1)C(F)(F)F

Standard InChI:  InChI=1S/C32H33Cl2F4N5O7S/c1-17(32(36,37)38)49-19-5-6-24(21(34)12-19)51(47,48)20-13-23(26(44)41-30(16-39)7-8-30)42(15-20)27(45)31(25-22(35)11-18(33)14-40-25)9-10-43(31)28(46)50-29(2,3)4/h5-6,11-12,14,17,20,23H,7-10,13,15H2,1-4H3,(H,41,44)/t17-,20+,23-,31?/m0/s1

Standard InChI Key:  KLKAVPREINBPNI-UNWPBJHZSA-N

Associated Targets(Human)

CTSL Tclin Cathepsin L (3852 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSS Tchem Cathepsin S (3285 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 778.61Molecular Weight (Monoisotopic): 777.1414AlogP: 5.31#Rotatable Bonds: 8
Polar Surface Area: 159.00Molecular Species: NEUTRALHBA: 9HBD: 1
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 1#RO5 Violations (Lipinski): 3
CX Acidic pKa: 10.45CX Basic pKa: CX LogP: 4.07CX LogD: 4.07
Aromatic Rings: 2Heavy Atoms: 51QED Weighted: 0.35Np Likeness Score: -1.03

References

1.  (2014)  Azetidine derivatives, 

Source

Source(1):